Public Employees Retirement Association of Colorado Has $27,169,000 Stake in Cantel Medical Corp. (CMN)
Public Employees Retirement Association of Colorado held its position in Cantel Medical Corp. (NYSE:CMN) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 395,302 shares of the company’s stock at the end of the second quarter. Public Employees Retirement Association of Colorado owned about 0.96% of Cantel Medical Corp. worth $27,169,000 at the end of the most recent quarter.
A number of other institutional investors also recently added to or reduced their stakes in CMN. LS Investment Advisors LLC increased its stake in shares of Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock worth $104,000 after buying an additional 106 shares in the last quarter. BlackRock Inc. increased its stake in Cantel Medical Corp. by 119.5% in the first quarter. BlackRock Inc. now owns 2,355 shares of the company’s stock worth $168,000 after buying an additional 1,282 shares during the period. Bank of Montreal Can purchased a new stake in Cantel Medical Corp. during the second quarter worth about $203,000. Cypress Wealth Advisors LLC purchased a new stake in Cantel Medical Corp. during the first quarter worth about $210,000. Finally, Mariner Wealth Advisors LLC purchased a new stake in Cantel Medical Corp. during the first quarter worth about $216,000. 81.60% of the stock is owned by institutional investors.
Shares of Cantel Medical Corp. (NYSE:CMN) traded up 0.59% on Monday, hitting $79.08. The company’s stock had a trading volume of 81,154 shares. The stock has a market capitalization of $3.27 billion, a P/E ratio of 54.99 and a beta of 1.59. The stock’s 50 day moving average price is $77.24 and its 200 day moving average price is $71.01. Cantel Medical Corp. has a 52 week low of $53.64 and a 52 week high of $81.63.
Cantel Medical Corp. (NYSE:CMN) last released its earnings results on Thursday, September 29th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.11. The company earned $179 million during the quarter. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. Cantel Medical Corp.’s revenue for the quarter was up 18.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.39 EPS. On average, analysts forecast that Cantel Medical Corp. will post $1.98 earnings per share for the current fiscal year.
A number of research analysts have commented on CMN shares. Benchmark Co. set a $83.00 price objective on Cantel Medical Corp. and gave the stock a “buy” rating in a research note on Saturday, October 1st. Needham & Company LLC started coverage on Cantel Medical Corp. in a research note on Wednesday, August 24th. They set a “hold” rating on the stock.
In other news, Director Ann E. Berman sold 1,453 shares of the stock in a transaction on Friday, September 30th. The stock was sold at an average price of $77.56, for a total value of $112,694.68. Following the completion of the sale, the director now owns 5,424 shares in the company, valued at $420,685.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 15.30% of the stock is owned by insiders.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Stock Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related stocks with our FREE daily email newsletter.